Skip to main content
. 2019 Apr 25;2019(4):CD012663. doi: 10.1002/14651858.CD012663.pub2

Summary of findings 3. Should MRI be used to diagnose ISUP grade ≥ 2 prostate cancer in men suspected of having clinically significant prostate cancer?

Question: Should MRI be used to diagnose ISUP grade 2 or higher prostate cancer in men suspected of having clinically significant prostate cancer?
Population: men suspected of having clinically significant prostate cancer undergoing their first biopsy (biopsy‐naïve men) or a repeat biopsy (prior‐negative biopsy men)
Setting: university hospitals and specialized care centers
New test: MRI only | Cut‐off value: MRI score ≥ 3 out of 5
Reference test: template‐guided biopsy, which comprehensively samples all zones of the prostate | Threshold: ISUP grade 2 or higher prostate cancer
Pooled sensitivity: 0.91 (95% CI: 0.83 to 0.95) | Pooled specificity: 0.37 (95% CI: 0.29 to 0.46)
Test result Number of results per 1,000 men tested (95% CI) Number of participants (studies) Certainty of the evidence (GRADE)
Prevalence 10% Prevalence 30% Prevalence 40%
True positives 9 (83 to 95) 273 (249 to 285) 364 (332 to 380) 3091 (12) ⊕⊕○○ LOWa, b
False negatives 9 (5 to 17) 27 (15 to 51) 36 (20 to 68)
True negatives 333 (261 to 414) 259 (203 to 322) 222 (174 to 276) 3091 (12) ⊕⊕○○ LOWa, b
False positives 567 (486 to 639) 441 (378 to 497) 378 (324 to 426)
MRI: magnetic resonance imaging; ISUP: International Society of Urological Pathology; CI: confidence interval
aA considerable number of studies had a high or unclear risk of bias, mainly in the participant selection and reference standard domains.
 bA considerable, clinically relevant heterogeneity was observed across pooled study results.